Protalix BioTherapeutics (PLX) Treasury Shares (2012 - 2025)
Protalix BioTherapeutics' (PLX) quarterly Treasury Shares came in at $739594.0 in Q4 2025, down 14.28% year-on-year from $862816.0 in Q4 2024, and down 14.28% quarter-over-quarter from $862816.0 in Q4 2024.
Protalix BioTherapeutics (PLX) Treasury Shares (2012 - 2025) Analysis & Trends
Protalix BioTherapeutics' Treasury Shares history runs 10 years deep, the most recent figure standing at $739594.0 for Q4 2025.
- On a quarterly basis, Treasury Shares fell 14.28% year-over-year to $739594.0 in Q4 2025; TTM through Dec 2025 was $739594.0, a 14.28% decrease from a year earlier, with the FY2025 full-year figure at $739594.0, down 14.28% from the prior year.
- Treasury Shares retreated to $739594.0 in Q4 2025 per PLX's latest filing, from $862816.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q4 2023 and bottomed at $291474.0 in Q4 2022.
- The 5-year median for Treasury Shares is $739594.0 (2025), against an average of $705116.2.
- Across the five-year window, Treasury Shares slumped 36.36% in 2022 and jumped 302.67% in 2023, its largest moves.
- Year by year, Treasury Shares stood at $458027.0 in 2021, then slumped by 36.36% to $291474.0 in 2022, then soared by 302.67% to $1.2 million in 2023, then fell by 26.49% to $862816.0 in 2024, then declined by 14.28% to $739594.0 in 2025.
- Per Business Quant, the three latest PLX Treasury Shares figures stand at $739594.0 (Q4 2025), $862816.0 (Q4 2024), and $1.2 million (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 739,594.00 |
| Dec 31, 2025 | 739,594.00 |
| Dec 31, 2024 | 862,816.00 |
| Dec 31, 2024 | 862,816.00 |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 291,474.00 |
| Dec 31, 2022 | 291,474.00 |
| Dec 31, 2021 | 458,027.00 |
| Dec 31, 2021 | 458,027.00 |
| Dec 31, 2020 | 624,580.00 |
| Dec 31, 2020 | 624,580.00 |
| Dec 31, 2015 | 127,874.00 |
| Dec 31, 2015 | 127,874.00 |
| Dec 31, 2014 | 386,124.00 |
| Dec 31, 2014 | 386,124.00 |
| Dec 31, 2013 | 970,208.00 |
| Dec 31, 2013 | 970,208.00 |
| Dec 31, 2012 | 1.39 Mn |
| Dec 31, 2012 | 1.39 Mn |